Mark Youngblood, M.D., Ph.D., is chief resident in neurological surgery at Northwestern Memorial Hospital in Chicago. His research focuses on molecular approaches to identify therapeutically targetable vulnerabilities in brain tumors, with an emphasis on gliomas and meningiomas. His recent work in meningiomas explores epigenetic mechanisms of tumor formation and progression, development of a bioresorbable platform for local chemotherapy delivery, and translation of novel immunotherapeutic approaches. He has received support for these and other projects from the National Institutes of Health, the U.S. Department of Defense, the American Brain Tumor Association, the Senior Society of Neurological Surgeons, and the Neurosurgery Research and Education Fund as principal investigator.

Youngblood earned a Ph.D. in genetics at Yale University under Murat Gunel and a bachelor’s of science in computer engineering from Georgia Tech. Before completing the MD/Ph.D. program at Yale, he worked as a microprocessor design engineer at Intel for three years.

REGISTER HERE

Lunch will be provided.

This event is part of the Dr. Herbert and Nicole Wertheim Leadership Lecture Series.